Insider Transactions in Q4 2021 at Eloxx Pharmaceuticals, Inc. (ELOX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Vijay Modur HEAD OF R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
64,373
-29.35%
|
$0
$0.72 P/Share
|
|
Dec 01
2021
|
Vijay Modur HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
219,326
+50.0%
|
-
|
|
Dec 01
2021
|
Sumit Aggarwal PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
81,933
-29.35%
|
$0
$0.72 P/Share
|
|
Dec 01
2021
|
Sumit Aggarwal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
279,158
+50.0%
|
-
|
|
Dec 01
2021
|
Alan Edmund Walts Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,695
+50.0%
|
-
|
|
Nov 29
2021
|
Daniel E. Geffken INTERIM CFO |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$0
$0.72 P/Share
|